Study of Sibutramine-Topiramate for Weight Loss in Real Practice
Part of Hormones & metabolism clinical trials.
This study looks back at medical records of patients who took sibutramine and topiramate together for weight loss in a doctor's office. Researchers want to understand how well this combination worked and what side effects patients experienced in everyday medical care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have obesity (BMI of 30 or higher) or overweight with a related health condition like diabetes, high cholesterol, or high blood pressure
- You were treated with both sibutramine and topiramate together for at least 3 months in a doctor's office
- Your doctor has medical records with at least two visits showing your weight, BMI, medication doses, and any side effects
- You were not pregnant or breastfeeding during treatment
- You do not have serious heart disease, uncontrolled high blood pressure, severe kidney or liver disease, or severe psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how obesity treatments work in real life for adults with a high body mass index. It aims to help doctors understand what works best for different people.
This study tests whether a combination of exercise and a weight loss medication (tirzepatide) can help people with overweight or obesity lose weight and improve their health. It's a good fit if you are between 30 and 65, have a BMI of 30–40 (or 27–29.9 with a related health risk), and are generally healthy enough for medication and exercise.
This trial tests an investigational drug called SGB-7342 to see if it helps with weight loss in people who are overweight or have obesity. It might be an option if you have a stable weight and haven't used certain weight-loss medications recently.
This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.
This study aims to better understand patients who are prescribed medications like Orlistat, Mysimba, Saxenda, Wegovy, or Mounjaro for obesity. It will help doctors improve treatments for you.
This one-year study tests whether a new medication called S1B-509 can help people with obesity lose weight when combined with diet and exercise. It compares the study drug to an inactive placebo to see if it works and is safe.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.